An Open Label Randomised Controlled Trial of Probiotics for Primary Prophylaxis of Hepatic Encephalopathy in Patients with Cirrhosis

Abstract

Background: Hepatic encephalopathy (HE) is associated with poor prognosis. Probiotics alter gut flora with non-urease producing organism with decrease ammonia production. Present study assessed efficacy of probiotics for primary prophylaxis of HE.